As the new year begins, Han Kun Law Offices is pleased to announce the 2023 promotion of new partners. These new partners are based across Han Kun's offices, covering practice areas such as private equity, venture capital, mergers and acquisitions, domestic and overseas securities issuances and listings, banking finance, aviation and aviation finance, structured finance, asset securitization, fintech, asset management, project finance, foreign direct investment, corporate compliance, and dispute resolution.
Han Kun is committed to providing young lawyers with opportunities for further development, encouraging them to give full play to their abilities and helping them to quickly excel by providing more opportunities for responsibility and leadership. Han Kun values the vitality of these young lawyers and expects them to contribute to the firm's development by consistently upholding Han Kun's spirit of always aiming high and adhering to our philosophy of professionalism. Facing the new journey in 2023, let us join hands to tackle new challenges and fulfill new expectations!
Ms. Chen specializes in private equity and venture capital investment, mergers and acquisitions, onshore and offshore listings, foreign investment, etc. She is knowledgeable of and experienced in relevant corporate structures and project management. Ms. Chen has represented many Chinese and international investment funds and companies in a wide variety of cross-border transactions in different industries such as telecommunications, internet, information technology, entertainment, consumer goods, healthcare, biotechnology, and pharmaceuticals.
Mr. Deng specializes in securities-related dispute resolution. He has in-depth knowledge of and extensive experience in handling statutory liability disputes involving financial institutions, such as those arising from securities misrepresentation, trustee fiduciary duties, and suitability obligations. Mr. Deng previously worked in the Legal and Compliance Department of a leading securities company. He has kept in close contact with the industry for over a decade, and has developed profound insights in securities business and law as well as regulatory risk response. Mr. Deng's clients mainly include listed companies and financial institutions in the securities and banking industries.
Mr. Lin focuses on handling dispute resolution cases arising from business investments and financings, red chip investments, control contests, private equity and financial management, mergers and acquisitions, cross-border investment and trade, real estate and construction projects, etc. Mr. Lin attaches great importance to combining dispute resolution with non-contentious legal services, and excels at resolving disputes by drawing on his transactional lawyer experience and through various ADR (alternative dispute resolution) measures.
Mr. Liu specializes in dispute resolution, with a focus on complicated cross-border commercial and corporate control disputes, and has represented clients in handling a series of influential cases. Mr. Liu has an educational and practice background in both Chinese law and common law and is familiar with both legal systems. Mr. Liu has extensive experience in foreign-related/international arbitration, having represented or advised clients in arbitration proceedings under the rules of arbitration institutions in mainland China, Hong Kong, London, Singapore, etc. Also, Mr. Liu has been advising both domestic and overseas clients on commercial disputes relating to international trade and all types of maritime cases.
Mr. Liao specializes in general banking matters, fintech, asset management transactions, blockchain and cryptocurrency, real property finance, and financial institution set-up and investment. Mr. Liao represents various commercial banks in a variety of financing transactions, including structured finance, acquisition finance, and real property finance. Mr. Liao assists fintech enterprises in product design and compliance, investing in fintech enterprises, investing in and setting up financial institutions. Mr. Liao also represents trust companies in a variety of domestic and cross-border asset management transactions.
Ms. Meng specializes in aviation finance, bank finance, financial institution establishment, and corporate compliance. She is knowledgeable of relevant PRC industry policies, corporate structures, and investment and project management and has extensive practical experience. Ms. Meng represents clients in leasing and financing projects involving various types of aeronautical facilities and other high-value equipment. She has advised on a wide range of financing transactions such as bilateral loans, syndicated loans, trade finance, as well as convertible bond transactions, leveraged finance, and non-performing asset disposals.
Jinsong (Jason) Song
Mr. Song specializes in private equity and venture capital, mergers and acquisitions, foreign investment, and capital markets, among other areas. He has represented institutional investors and corporate clients in over a hundred transactions in diverse industries such as internet, telecommunications, bio-medicine, consumer goods, automotive logistics, energy, education, gaming, real estate, and fintech, providing full-scope legal services spanning deal structure design, legal document drafting and negotiation, and project closing.
Ms. Sun specializes in public and private financing, mergers and acquisitions, incorporation and corporate restructuring, and foreign direct investment. She has represented Chinese and international companies in a wide variety of cross-border transactions in diverse industries such as telecommunications, internet, consumer goods, healthcare, biotechnology, and pharmaceuticals.
Ms. Wang's primary practice areas are mergers, acquisitions and reorganizations, private equity and venture capital, and foreign investment. She is knowledgeable of relevant industry policies, corporate structures, and project management and has extensive practical experience. Ms. Wang has developed a broad client base consisting of multinationals, foreign-invested companies, leading funds, as well as SOEs and start-ups. Ms. Wang also focuses on the areas of life sciences, bio-medicine and healthcare, advising clients on corporate, compliance and transaction issues such as those related to the biosecurity law and human genetic resources, clinical trials, product marketing authorization, GxP compliance, healthcare data compliance, exclusive product distribution, as well as cross-border drug and patent right license-in and commercialization projects.